Shock, Sepsis, and Organ Failure: Scavenging of Nitric Oxide and Inhibition of its Production
Editat de Günther Schlag, Heinz Redlen Limba Engleză Hardback – 17 feb 1999
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 719.02 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 4 noi 2012 | 719.02 lei 6-8 săpt. | |
Hardback (1) | 723.57 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 17 feb 1999 | 723.57 lei 6-8 săpt. |
Preț: 723.57 lei
Preț vechi: 761.65 lei
-5% Nou
Puncte Express: 1085
Preț estimativ în valută:
138.47€ • 142.86$ • 117.20£
138.47€ • 142.86$ • 117.20£
Carte tipărită la comandă
Livrare economică 04-18 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783540645443
ISBN-10: 3540645446
Pagini: 312
Ilustrații: XIV, 293 p.
Dimensiuni: 170 x 244 x 22 mm
Greutate: 0.61 kg
Ediția:1999
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3540645446
Pagini: 312
Ilustrații: XIV, 293 p.
Dimensiuni: 170 x 244 x 22 mm
Greutate: 0.61 kg
Ediția:1999
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchDescriere
At the Sixth Wiggers Bernard Conference, a group of scientists from various fields discussed new findings relating to nitric oxide synthase inhibitor in shock, sepsis, and organ failure. This meeting was dedicated to the presentation and discussion of positive and negative findings related to the use of NOS inhibitors, the issue of specific and non-specific inhibitors and the role of nitric oxide-oxygen radical interactions. Both experimental and clinical data were presented in the trauma and sepsis field. With appropriate dosing and timing the use of NOS inhibitors seems to be beneficial at least in severe sepsis situations, but some inhibitors and overdosing can be potentially dangerous.
Cuprins
Inhibition of the Overproduction of Nitric Oxide in Septic Shock Using NG-Methyl-L-Arginine.- Successful Administration of the NO Synthase Inhibitor 546C88 as a Delayed Continous Infusion in a Baboon Model of Septic Shock.- Clinical Aspects of Nitric Oxide (NO?) Blockade with Pyridoxylated-Hemoglobin Polyoxyethylene Conjugate (PHP).- Norepinepherine Versus L-NMMA in Hyperdynamic Septic Shock.- Roles for Induced Nitric Oxide in Endotoxic and Hemorrhagic Shock.- Role of Nitric Oxide in the Regulation of Cardiovascular Performance: Clinical Implication for Sepsis and Congestive Heart Failure.- Inducible NOS and Other Novel Mediators of Inflammation in Brain Trauma.- Nitric Oxide and Leukocyte Adhesion: Experience with NO Inhibitors, NO Donors and iNOS-Deficient Mice.- Cytokine Control of Nitric Oxide Production: Therapeutic Possibilities.- Peroxynitrite: the Dark Side of Nitric Oxide-Effect of Mercaptoethylguanidine (MEG), a Combined Inhibitor of Inducible Nitric Oxide Synthase and Scavenger of Peroxynitrite in Shock, Inflammation, and Ischemia-Reperfusion Injury.- Actions of Selective and Non-Selective Nitric Oxide Synthase Inhibitors on Multiple-Organ Microvascular Injury Provoked by Lipopolysaccharide.- Inhibition of Nitric Oxide Synthases by the 4-Amino Analogue of Tetrahydrobiopterin.- Effects of Nitric Oxide Inhibitors and Hemoglobin in Sepsis.
Textul de pe ultima copertă
At the Sixth Wiggers Bernard Conference, a group of scientists from various fields discussed new findings relating to nitric oxide synthase inhibitor in shock, sepsis, and organ failure. This meeting was dedicated to the presentation and discussion of positive and negative findings related to the use of NOS inhibitors, the issue of specific and non-specific inhibitors and the role of nitric oxide-oxygen radical interactions. Both experimental and clinical data were presented in the trauma and sepsis field. With appropriate dosing and timing the use of NOS inhibitors seems to be beneficial at least in severe sepsis situations, but some inhibitors and overdosing can be potentially dangerous.
Caracteristici
Includes supplementary material: sn.pub/extras